Empery Asset Management’s Bone Biologics Corp Warrants BBLGW Stock Holding History

Empery Asset Management’s Portfolio BBLGW Stock Details BBLGW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$18K	Hold	4,682	–	–	0.11%	62
2022 Q2	$20K	Hold	4,682	–	–	0.11%	55
2022 Q1	$48K	Sell	4,682 -80	-2%	-$1.07K	0.23%	47
2021 Q4	$100K	Buy	+4,762	New	+$119K	0.21%	41

Other funds holding BBLGW

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Empery Asset Management's BBLGW Position: Q3 2022 in Review

Empery Asset Management held its Bone Biologics Corp Warrants (BBLGW) position steady in Q3 2022 at 4,682 shares worth $18K. The position accounts for 0.11% of the portfolio, ranked #62.

Empery Asset Management first reported a position in BBLGW in Q4 2021 and has held it in 4 quarters since. The position peaked at $100K in Q4 2021. 5 funds tracked by Wall St. Rank hold BBLGW as of Q3 2022.

Empery Asset Management held 4,682 shares of Bone Biologics Corp Warrants worth $18K as of Q3 2022.
Empery Asset Management left its Bone Biologics Corp Warrants share count unchanged in Q3 2022.
Bone Biologics Corp Warrants made up 0.11% of Empery Asset Management's portfolio in Q3 2022, its #62 holding.
Empery Asset Management first reported a position in Bone Biologics Corp Warrants in Q4 2021 and has held it in 4 quarters since.
Empery Asset Management's Bone Biologics Corp Warrants position peaked at $100K in Q4 2021.
5 funds tracked by Wall St. Rank held Bone Biologics Corp Warrants as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.